Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer

NCT01891227 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Bendamustine

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie